These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 26966048)

  • 1. Pharmacotherapy for Dravet Syndrome.
    Wallace A; Wirrell E; Kenney-Jung DL
    Paediatr Drugs; 2016 Jun; 18(3):197-208. PubMed ID: 26966048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacologic treatment of Dravet syndrome.
    Chiron C; Dulac O
    Epilepsia; 2011 Apr; 52 Suppl 2():72-5. PubMed ID: 21463285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing Landscape of Dravet Syndrome Management: An Overview.
    Samanta D
    Neuropediatrics; 2020 Apr; 51(2):135-145. PubMed ID: 32079034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Dravet Syndrome.
    Wirrell EC
    Can J Neurol Sci; 2016 Jun; 43 Suppl 3():S13-8. PubMed ID: 27264138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dravet syndrome: Treatment options and management of prolonged seizures.
    Cross JH; Caraballo RH; Nabbout R; Vigevano F; Guerrini R; Lagae L
    Epilepsia; 2019 Dec; 60 Suppl 3():S39-S48. PubMed ID: 31904119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current therapeutic procedures in Dravet syndrome.
    Chiron C
    Dev Med Child Neurol; 2011 Apr; 53 Suppl 2():16-8. PubMed ID: 21504427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked efficacy of combined three-drug therapy (Sodium Valproate, Topiramate and Stiripentol) in a patient with Dravet syndrome.
    Morimoto M; Shimakawa S; Hashimoto T; Kitaoka T; Kyotani S
    J Clin Pharm Ther; 2018 Aug; 43(4):571-573. PubMed ID: 29265387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-Refractory Dravet Syndrome: Considerations for Novel Medications.
    Lopez JC; Pare JR; Blackmer AB; Orth LE
    J Pediatr Health Care; 2022; 36(5):479-488. PubMed ID: 35987555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dravet syndrome as a cause of epilepsy and learning disability].
    Lund C; Bremer A; Lossius MI; Selmer KK; Brodtkorb E; Nakken KO
    Tidsskr Nor Laegeforen; 2012 Jan; 132(1):44-7. PubMed ID: 22240828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stiripentol for the treatment of seizures in Dravet syndrome.
    Eschbach K; Knupp KG
    Expert Rev Clin Pharmacol; 2019 May; 12(5):379-388. PubMed ID: 31017478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an antiseizure drug screening platform for Dravet syndrome at the NINDS contract site for the Epilepsy Therapy Screening Program.
    Pernici CD; Mensah JA; Dahle EJ; Johnson KJ; Handy L; Buxton L; Smith MD; West PJ; Metcalf CS; Wilcox KS
    Epilepsia; 2021 Jul; 62(7):1665-1676. PubMed ID: 34002394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do children with Dravet syndrome continue to benefit from stiripentol for long through adulthood?
    Chiron C; Helias M; Kaminska A; Laroche C; de Toffol B; Dulac O; Nabbout R; An I
    Epilepsia; 2018 Sep; 59(9):1705-1717. PubMed ID: 30132836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complex febrile Seizures or Dravet syndrome?: Description of 3 case reports].
    Hernández M; Pedraza M; Mesa T; Troncoso M
    Rev Chil Pediatr; 2014 Oct; 85(5):588-93. PubMed ID: 25697436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stiripentol for the treatment of seizures associated with Dravet syndrome.
    Chiron C
    Expert Rev Neurother; 2019 Apr; 19(4):301-310. PubMed ID: 30900478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
    Gil-Nagel A; Falip M; Sánchez-Carpintero R; Abad-Sazatornil MR; Poveda JL; Aibar JÁ; Cardenal-Muñoz E; Aras LM; Sánchez R; Sancho-López A; Trillo-Mata JL; Torrejón M; Gil A
    Epilepsy Behav; 2022 Jul; 132():108711. PubMed ID: 35588562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stiripentol: A Review in Dravet Syndrome.
    Frampton JE
    Drugs; 2019 Nov; 79(16):1785-1796. PubMed ID: 31617141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dravet syndrome.
    Lagae L
    Curr Opin Neurol; 2021 Apr; 34(2):213-218. PubMed ID: 33395108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dravet syndrome: seizure control and gait in adults with different SCN1A mutations.
    Rilstone JJ; Coelho FM; Minassian BA; Andrade DM
    Epilepsia; 2012 Aug; 53(8):1421-8. PubMed ID: 22780858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen.
    Dressler A; Trimmel-Schwahofer P; Reithofer E; Mühlebner A; Gröppel G; Reiter-Fink E; Benninger F; Grassl R; Feucht M
    Epilepsy Res; 2015 Jan; 109():81-9. PubMed ID: 25524846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From genotype to phenotype in Dravet disease.
    Gataullina S; Dulac O
    Seizure; 2017 Jan; 44():58-64. PubMed ID: 27817982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.